Insider Transactions in Q4 2024 at Scholar Rock Holding Corp (SRRK)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2024
|
Invus Public Equities, L.P. |
SELL
Open market or private sale
|
Direct |
1,600,000
-14.75%
|
$65,600,000
$41.65 P/Share
|
|
Nov 25
2024
|
Invus Public Equities, L.P. |
SELL
Open market or private sale
|
Direct |
409,433
-0.74%
|
$15,967,887
$39.34 P/Share
|
|
Nov 25
2024
|
Jing L. Marantz CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,375
-2.06%
|
$248,625
$39.49 P/Share
|
|
Nov 25
2024
|
Jing L. Marantz CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,375
+7.45%
|
$51,000
$8.59 P/Share
|
|
Nov 22
2024
|
Jing L. Marantz CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,145
-2.86%
|
$64,350
$30.01 P/Share
|
|
Nov 22
2024
|
Jing L. Marantz CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,145
+2.78%
|
$17,160
$8.59 P/Share
|
|
Nov 12
2024
|
Michael Gilman |
BUY
Bona fide gift
|
Direct |
37,459
+42.37%
|
-
|
|
Nov 12
2024
|
Michael Gilman |
SELL
Bona fide gift
|
Indirect |
37,459
-100.0%
|
-
|
|
Nov 11
2024
|
Jing L. Marantz CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,105
-2.81%
|
$63,150
$30.0 P/Share
|
|
Nov 11
2024
|
Jing L. Marantz CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,105
+2.73%
|
$16,840
$8.59 P/Share
|
|
Oct 08
2024
|
Edward H Myles COO & CFO |
SELL
Open market or private sale
|
Direct |
37,187
-18.76%
|
$1,264,358
$34.9 P/Share
|
|
Oct 08
2024
|
Edward H Myles COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
37,187
+15.79%
|
$371,870
$10.0 P/Share
|
|
Oct 07
2024
|
Edward H Myles COO & CFO |
SELL
Open market or private sale
|
Direct |
206,240
-18.28%
|
$5,568,480
$27.19 P/Share
|
|
Oct 07
2024
|
Edward H Myles COO & CFO |
SELL
Exercise of conversion of derivative security
|
Direct |
206,240
-35.96%
|
$2,681,120
$13.83 P/Share
|
|
Oct 07
2024
|
Tracey Sacco CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
30,000
-19.6%
|
$750,000
$25.91 P/Share
|
|
Oct 07
2024
|
Tracey Sacco CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+27.45%
|
$300,000
$10.0 P/Share
|
|
Oct 07
2024
|
Srinivas Akkaraju |
SELL
Open market or private sale
|
Indirect |
1,175,713
-6.11%
|
$35,271,390
$30.0 P/Share
|
|
Oct 07
2024
|
Jing L. Marantz CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
109,375
-24.77%
|
$2,953,125
$27.29 P/Share
|
|
Oct 07
2024
|
Jing L. Marantz CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
109,375
+37.51%
|
$875,000
$8.59 P/Share
|